Drug Examples Flashcards
Gabapentin
Used in the treatment of epilepsy
Blocks presynaptic Ca2+ channels - decreasing release of glutamate - decreases excitation
Carbamazepine
Used in treatment of epilepsy - decreases excitation
Blocks postsynaptic Na+ channels - preventing AP generation
What are Benzodiazepines & Barbiturates examples of?
CNS depressants
Ketamine & PCP are…
Dissociative anaesthetics
Opium, heroin, fentanyl & oxyContin are…
Narcotic analgesics
LSD, mescaline, DMT, psilocybin, MDMA are…
Hallucinogens
Nitrous oxide, amyl nitrite, lighter gas & household aerosols are…
Inhalants
Cocaine, amphetamine, nicotine, MDMA are…
CNS stimulants
3 examples of NDC neuromuscular blockers
Tubocurarine
Pancuronium
Gallamine
Alcuronium
Atracurium
Vecuronium
2 examples of DNC neuromuscular blockers
Suxamethonium
Decamethonium
Suxamethonium
DNC neuromuscular blocker
Used in intubation
Scoline apnoea - individuals with mutant esterases which cannot metabolise suxamethonium
EDTA (chelating agent)
Used in treating lead poisoning - binds to lead and forms a less toxic chelate
Example of chemical antagonism
Salbutamol
Used in the treatment of asthma
Artificial adrenoceptor agonist - activates adrenoceptors in the lungs, causes the relaxation of bronchial smooth muscle
Targets b2 adrenoceptors found in the lungs rather than b1 adrenoceptors found in the heart - so the heart doesn’t race
Sulfonamides & sulfones
Antimalarial drugs which inhibit dihydropteroate synthase
Proguanil & pyrimethamine
Anti-malarial drugs which inhibit dihydrofolate reductase
Chloroquine, quinine, mefloquine
Antimalarial drugs
Inhibit haem polymerase - therefore preventing parasites from polymerising (toxic) haem to insoluble hemozoin
Artemisinin (usually used in combination therapy, e.g. Artesunate & mefloquine)
Anti-malarial drug
Treats malaria with highly drug-resistant strains
Believed to work through a redox mechanism
AZT, Lamivudine, Abacavir
Nucleoside reverse transcriptase inhibitors (NRTs)
Anti-HIV drugs
Nevirapine, efavirenz, delavirdine
Non-nucleoside reverse transcriptase inhibitors (NNRTs)
Non-competitive, bind to allosteric site - induces conformational change to active site - preventing activity of RT
Saquinavir, ritonavir, indinavir
Anti-HIV drugs
Protease inhibitors
Prevent cleavage of propeptide into structural proteins
Varenicline
Smoking cessation therapy
Partial agonist of alpha-4, beta-2 nAChRs - causes a moderate & sustained increase in mesolimbic dopamine levels
Competitive binding with nicotine may reduce rewarding properties of nicotine during a relapse
Disulfiram
Medication used to treat chronic alcoholism
Creates an unpleasant reaction when alcohol is consumed
Inhibits aldehyde dehydrogenase (which breaks down acetaldehyde —> acetic acid) in the liver
Causing a build-up of acetaldehyde, a toxic substance that causes symptoms such as flushing, nausea & vomiting
Statins
Given to many patients to decrease the risk of cardiovascular disease
*statin-induced myopathy (muscle pain)
Suxamethonium, Decamethonium, suxethonium
DNC neuromuscular blockers
Streptomycin, neomycin, kanamycin
Aminoglycoside antibiotics
Tetraethylammonium (TEA)
4-aminopyridine
K+ channel blockers
Lecanemab (antibody therapy)
Recently developed treatment for AD
Targets amyloid accumulation directly - decreases amyloid plaques
Thus slowing onset / progression of symptoms of cognitive decline
Carbidopa
AADC inhibitor
Used in combination with L-DOPA precursor in the treatment of Parkinson’s disease
Prevents the conversion of L-DOPA to dopamine in the periphery so that it can cross the blood-brain barrier
Pramipexole, ropinirole, bromocriptine
Used in treatment of Parkinson’s disease
D2 receptor agonists - mimic the effects of dopamine in the brain by binding to dopamine receptors
Tolcapone
Used in the treatment of Parkinson’s disease
(Central) COMT inhibitor
Decreases metabolism of dopamine
Tiagabine
Used in the treatment of epilepsy
Blocks GABA re-uptake - increasing inhibition
Chlorpromazine
Used in the treatment of schizophrenia
D2 (metabotrophic, postsynaptic) receptor antagonist - decreases effects of excess dopamine signalling
Clozapine
Example of ‘atypical antipsychotics used in the treatment of schizophrenia
Antagonise D2 & 5-HT2A receptors
(Also work on negative symptoms)